Lipocine Inc. financial data

Symbol
LPCN on Nasdaq
Location
Salt Lake City, United States
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 12.43 % +2.2%
Debt-to-equity 0.09 % -2.6%
Return On Equity -0.31 % -59.9%
Return On Assets -0.28 % -60.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5,551,931 shares +3.8%
Common Stock, Shares, Outstanding 5,420,256 shares +1.4%
Entity Public Float 42,800,000 USD +67.2%
Common Stock, Value, Issued 8,870 USD +0.08%
Weighted Average Number of Shares Outstanding, Basic 5,413,149 shares +1.2%
Weighted Average Number of Shares Outstanding, Diluted 5,413,149 shares +1.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 114,574 USD
Revenue from Contract with Customer, Excluding Assessed Tax 54,990 USD
Research and Development Expense 6,978,990 USD -12.3%
General and Administrative Expense 3,653,802 USD -30.6%
Operating Income (Loss) -6,310,100 USD -19.2%
Nonoperating Income (Expense) 835,062 USD -32.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5,475,038 USD -35%
Income Tax Expense (Benefit) 200 USD 0%
Net Income (Loss) Attributable to Parent -5,475,238 USD -35%
Earnings Per Share, Basic -0.59 USD/shares -43.9%
Earnings Per Share, Diluted -0.59 USD/shares -34.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3,901,040 USD +4.2%
Assets, Current 15,930,140 USD -22.3%
Property, Plant and Equipment, Net 119,274 USD -30.1%
Other Assets, Noncurrent 23,753 USD 0%
Assets 16,073,167 USD -22.3%
Accounts Payable, Current 861,452 USD +2%
Accrued Liabilities, Current 749,667 USD -42%
Liabilities, Current 1,931,119 USD +22.1%
Liabilities 1,931,119 USD +22.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax 4,627 USD -53.5%
Retained Earnings (Accumulated Deficit) -207,026,283 USD -2.7%
Stockholders' Equity Attributable to Parent 14,142,048 USD -26%
Liabilities and Equity 16,073,167 USD -22.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1,969,257 USD -1.8%
Net Cash Provided by (Used in) Investing Activities -882,073 USD +78.4%
Common Stock, Shares Authorized 75,000,000 shares -62.5%
Common Stock, Shares, Issued 5,420,592 shares +1.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2,851,330 USD -68.7%
Deferred Tax Assets, Valuation Allowance 48,222,797 USD +0.98%
Deferred Tax Assets, Gross 48,231,575 USD +0.98%
Payments to Acquire Property, Plant, and Equipment 4,000 USD -85.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -5,480,553 USD -35.9%
Lessee, Operating Lease, Liability, to be Paid 157,200 USD +2.5%
Property, Plant and Equipment, Gross 1,388,372 USD +6.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 62,880 USD +2.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 62,880 USD +2.5%
Preferred Stock, Shares Issued 88,511 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital 221,195,546 USD +0.23%
Preferred Stock, Shares Outstanding 88,511 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%